全文获取类型
收费全文 | 113362篇 |
免费 | 8479篇 |
国内免费 | 3010篇 |
专业分类
耳鼻咽喉 | 443篇 |
儿科学 | 2580篇 |
妇产科学 | 2162篇 |
基础医学 | 10768篇 |
口腔科学 | 1267篇 |
临床医学 | 15402篇 |
内科学 | 17844篇 |
皮肤病学 | 621篇 |
神经病学 | 4951篇 |
特种医学 | 4331篇 |
外国民族医学 | 13篇 |
外科学 | 8417篇 |
综合类 | 19984篇 |
现状与发展 | 7篇 |
预防医学 | 11295篇 |
眼科学 | 995篇 |
药学 | 11520篇 |
170篇 | |
中国医学 | 8759篇 |
肿瘤学 | 3322篇 |
出版年
2024年 | 194篇 |
2023年 | 1510篇 |
2022年 | 2306篇 |
2021年 | 4393篇 |
2020年 | 4119篇 |
2019年 | 3452篇 |
2018年 | 3378篇 |
2017年 | 3575篇 |
2016年 | 3762篇 |
2015年 | 3706篇 |
2014年 | 7167篇 |
2013年 | 7590篇 |
2012年 | 6592篇 |
2011年 | 7057篇 |
2010年 | 5464篇 |
2009年 | 4980篇 |
2008年 | 5030篇 |
2007年 | 5325篇 |
2006年 | 4600篇 |
2005年 | 4199篇 |
2004年 | 3702篇 |
2003年 | 3294篇 |
2002年 | 2909篇 |
2001年 | 2703篇 |
2000年 | 2270篇 |
1999年 | 2006篇 |
1998年 | 1772篇 |
1997年 | 1867篇 |
1996年 | 1579篇 |
1995年 | 1488篇 |
1994年 | 1445篇 |
1993年 | 1080篇 |
1992年 | 1106篇 |
1991年 | 979篇 |
1990年 | 792篇 |
1989年 | 765篇 |
1988年 | 724篇 |
1987年 | 577篇 |
1986年 | 536篇 |
1985年 | 771篇 |
1984年 | 638篇 |
1983年 | 407篇 |
1982年 | 574篇 |
1981年 | 450篇 |
1980年 | 391篇 |
1979年 | 314篇 |
1978年 | 250篇 |
1977年 | 231篇 |
1976年 | 220篇 |
1975年 | 153篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
3.
《Journal of pediatric surgery》2023,58(9):1613-1617
BackgroundThe goal of this study was to characterize contemporary performance benchmarks and risk factors associated with negative appendectomy (NA) in children with suspected appendicitis.MethodsA multicenter retrospective cohort analysis of children undergoing appendectomy for suspected appendicitis was performed using data from the 2016–2021 NSQIP-Pediatric Appendectomy Targeted Public Use Files. Multivariable regression was used to evaluate the influence of year, age, sex, and WBC count on NA rate, and to generate rate estimates for NA based on different combinations of demographic characteristics and WBC profiles.Results100,322 patients were included from 140 hospitals. The overall NA rate was 2.4%, and rates decreased significantly during the study period (2016: 3.1% vs. 2021: 2.3%, p < 0.001). In adjusted analyses, the highest risk for NA was associated with a normal WBC (<9000/mm3; OR 5.31 [95% CI: 4.87–5.80]), followed by female sex (OR 1.55 [95% CI: 1.42–1.68]) and age <5 years (OR 1.64 [95% CI 1.39, 1.94]). Model-estimated risk for NA varied significantly across demographic and WBC strata, with a 14.4-fold range in rates between subgroups with the lowest and highest predicted risk (males 13–17 years with elevated WBC [1.1%] vs. females 3–4 years with normal WBC [15.8%]).ConclusionsContemporary NA rates have decreased over time, however NA risk remains high in children without a leukocytosis, particularly for girls and children <5 years of age. These data provide contemporary performance benchmarks for NA in children with suspected appendicitis and identify high-risk populations where further efforts to mitigate NA risk should be targeted.Level of EvidenceIII. 相似文献
4.
采用Mimics对心脏进行三维重构,用3-matic进行模型优化以及模型误差分析,对左心室室壁运动做速度分布假设,基于UDF宏文件对左心室室壁运动编写程序,将血液视为非牛顿流体,采用动网格技术研究不同血压对左心室血液流动的影响。模拟发现当左心室收缩时,压力梯度明显,内部压力减小。当左心室舒张时,内部压力逐渐增高。二尖瓣口处的速率先增大后减小。血压升高,左心室内剪切应力持续增大,极易破坏红细胞结构,产生溶血现象,导致心脏功能紊乱。 相似文献
5.
6.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献
7.
《The Journal of thoracic and cardiovascular surgery》2023,165(1):94-103.e24
ObjectiveNew-onset postoperative atrial fibrillation (POAF) after cardiac surgery is common, with rates up to 60%. POAF has been associated with early and late stroke, but its association with other cardiovascular outcomes is less known. The objective was to perform a meta-analysis of the studies reporting the association of POAF with perioperative and long-term outcomes in patients with cardiac surgery.MethodsWe performed a systematic review and a meta-analysis of studies that presented outcomes for cardiac surgery on the basis of the presence or absence of POAF. MEDLINE, EMBASE, and the Cochrane Library were assessed; 57 studies (246,340 patients) were selected. Perioperative mortality was the primary outcome. Inverse variance method and random model were performed. Leave-one-out analysis, subgroup analyses, and metaregression were conducted.ResultsPOAF was associated with perioperative mortality (odds ratio [OR], 1.92; 95% confidence interval [CI], 1.58-2.33), perioperative stroke (OR, 2.17; 95% CI, 1.90-2.49), perioperative myocardial infarction (OR, 1.28; 95% CI, 1.06-1.54), perioperative acute renal failure (OR, 2.74; 95% CI, 2.42-3.11), hospital (standardized mean difference, 0.80; 95% CI, 0.53-1.07) and intensive care unit stay (standardized mean difference, 0.55; 95% CI, 0.24-0.86), long-term mortality (incidence rate ratio [IRR], 1.54; 95% CI, 1.40-1.69), long-term stroke (IRR, 1.33; 95% CI, 1.21-1.46), and longstanding persistent atrial fibrillation (IRR, 4.73; 95% CI, 3.36-6.66).ConclusionsThe results suggest that POAF after cardiac surgery is associated with an increased occurrence of most short- and long-term cardiovascular adverse events. However, the causality of this association remains to be established. 相似文献
8.
9.
10.
《Vaccine》2022,40(18):2525-2527